2543. How Bacteremia Strategy Trials Will Impact the Clinical Practice of Infectious Diseases
Session: Symposium: Strategy Trials: A New Paradigm in Infectious Diseases Research
Saturday, October 6, 2018: 2:50 PM
Room: W 2005-2024
Helen W. Boucher, MD, FIDSA, Tufts University, Boston, MA; Infectious Diseases, Tufts Medical Center, Boston, MA

Helen Whamond Boucher, MD, FIDSA, FACP
Helen Boucher is director of the infectious diseases fellowship program and staff physician in the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center and Associate Professor of Medicine at Tufts University School of Medicine in Boston, Massachusetts.
Dr Boucher received her medical degree from the University of Texas Medical School at Houston. She completed her internship, residency and Chief Residency in Internal Medicine at the New England Deaconess Hospital and her clinical and research fellowships in infectious diseases at the Beth Israel Deaconess Medical Center. Dr Boucher is board certified in internal medicine and Infectious diseases.
Dr Boucher’s clinical interests include infections in immunocompromised patients with an emphasis on transplant-related bacterial and fungal infections and human immunodeficiency virus as well as S. aureus infections. Her research interests focus on S. aureus and the development of new anti-infective agents. She is the author or coauthor of numerous abstracts, chapters and peer-reviewed articles, which have been published in such journals as The New England Journal of Medicine, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, and Drugs.
Dr Boucher is a member of several professional organizations, among them the Infectious Diseases Society of America, the American Society for Microbiology, and the American Medical Association. In 1998, the Massachusetts Infectious Diseases Society awarded Dr Boucher the Edward H. Kass Award for Clinical Excellence. In May 2006, she was elected to the Antimicrobial Availability Task Force (AATF) of the Infectious Diseases Society of America (IDSA) and in October, 2007, she was elected to the Research Committee of the IDSA. Dr Boucher was elected a Fellow in the American College of Physicians in 2008 and Fellow of the IDSA in 2011.
.


Disclosures:

H. W. Boucher, Merck & Co., Inc.: Scientific Advisor , Consulting fee .

<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.